DenovAI Biotech
Dynamic Protein Design
StartupDenovAI Biotech is a Rehovot-based startup in the Health Tech & Life Sciences sector, established in 2023. Dynamic Protein Design. The company has raised a total of $4M across 2 funding rounds, currently at the Seed stage. DenovAI Biotech was founded by Kashif Sadiq. Key investors include Amiti Ventures, AION Labs, Pfizer Ventures, among 6 total investors. The company has 11-50 employees. Core technologies: Artificial Intelligence, Biologicals, Molecules.
With $4M in total funding, DenovAI Biotech is a Seed-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: R&D.
- StageSeed
- ProductR&D
- ModelB2B
- Employees11-50
- HQRehovot
- Last Round$3M
- Amiti Ventures
- AION LabsLead
- Pfizer Ventures
6 investors total
Kashif SadiqFounder & CEO
2 articles covered by sources including www.the-microbiologist.com,
www.azorobotics.com.
What does DenovAI Biotech do?
DenovAI is developing foundational technology platforms that can design proteins de novo - completely from scratch. The company is starting the journey to design next generation therapeutics like high-affinity antibodies, small protein and peptide biologics, and diagnostic reporters - all tailored to bind to their specific targets. Its AI-based platform for rapid de novo antibody discovery will design high-affinity binders to epitopes of choice, reduce the discovery process from months to days and broaden the scope of therapy to many more diseases. The platform for de novo protein design can design bespoke high-affinity binders for targets of choice – unlocking many applications in biologics and diagnostics.
How much funding has DenovAI Biotech raised?
DenovAI Biotech has raised $4M in total funding across 2 rounds. The company is currently at the Seed stage. Key investors include Amiti Ventures, AION Labs, Pfizer Ventures.
Who founded DenovAI Biotech?
DenovAI Biotech was founded in 2023 by Kashif Sadiq (Founder & CEO).
What sector is DenovAI Biotech in?
DenovAI Biotech operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drugs Discovery & Development, with core technologies in Artificial Intelligence, Biologicals, Molecules. Target customers: Healthcare & Life Sciences, Life Sciences, Pharmaceuticals, Biotechnology.
Where is DenovAI Biotech located?
DenovAI Biotech is based in 4 Oppenheimer Building B 17th Floor, Rehovot, 7670104, Israel.